They may carry an increased risk in the right setting, including concerns related to thyroid tumors, gallbladder disease, pancreatitis, and low blood sugar when used with certain other diabetes medications
Dual agonism (Tirzepatide) targets the GIP and GLP-1 receptors
PMID 11498540
Utilizing mail-back programs offered by Novo Nordisk or local pharmacy take-back services can help mitigate these risks and ensure your safety
If you are ready to explore a supervised, sustainable path, you need a provider who supports this patient-centered approach
However, a better strategy is to ensure you support the bodys innate antioxidant system through a rigorous diet rich in phytochemicals and food diversity and then to provide the sulphur containing amino acid, cysteine in the form of NAC which is easy to take and only needs to be taken in small amounts to have a significant effect